Cuttsy+Cuttsy®

In case you missed it… Last month we featured in The Guardian as part of the Innovations in Patient Care campaign. Focused on boosting clinical trial access and make patients more health empowered, we looked at how: 🔹Patient-centric trial design is helping to better meet peoples needs, including home treatment options and fewer tests 🔹Activated patients are better equipped for clinical trials, but many with lower health literacy rely on doctors for decisions. 🔹Inclusive education and awareness are needed to help more people understand and participate in clinical trials. Find out more about what can be done to make clinical trials available to everyone. 🔎 https://lnkd.in/dg_BpbTd #ClinicalTrials #PatientCentric #ActivatedPatient

Many clinical trials still report the same recruitment and retention issues that the industry has faced for years… Our new report: Integrating ‘patient first’ into medicine development helps you approach some of these issues by shining a light on how to make trials approachable and accessible to everyone. This practical and integrated roadmap can be used to address some of the biggest challenges we face in healthcare and pharma today: https://lnkd.in/eMvk9qjq #ClinicalTrials #PatientFirst #Report

Last week the team travelled from far and wide to be together for our summer company day☀️ Following updates from the management team on what has been a fantastic first-half of the year, the team enjoyed spending some quality time together in the (long overdue) sunny weather 😎 #CompanyDay #Team #WherePeopleMatter

“Integrating ‘patient first’ into medicine development” has landed! Are you: ✔ Looking for some practical guidance to ensure your clinical trials are approachable and accessible to everyone?   ✔ Looking for a clear and actionable roadmap to support your future clinical trial progress and communication success?  ✔ Working in the clinical trial space, or just have an interest in medicine development? If the answer’s yes, this report is definitely for you. Click here to access the report and gain valuable insights for you and your business: https://lnkd.in/eMvk9qjq #PatientFirst #PatientEngagement #PatientInvolvement

Discover how Katie found her passion for #Medcomms and a fulfilling career here at Cuttsy+Cuttsy ✨ #HealthcareCommunications #HealthcareMarketing #MedicalWriter

Have you ever participated in a clinical trial, invested your time and effort, only to be left in the dark about the study’s results? You’re not alone. A staggering 68% of clinical trial participants never hear about the outcomes. 🚨 It’s clear that there’s a disconnect between the valuable contributions of participants and the communication of trial results. Discover why sharing trial results is crucial for respect, health decisions and fostering partnerships. Read our latest blog to find out more and how we can bridge this gap: https://lnkd.in/dgJJAp68 #ClinicalTrials #Transparency #PatientFirst Katie Breen

There’s a brand new Cuttsy+Cuttsy report incoming… “Integrating ‘patient first’ into medicine development.”  It’s been written for everyone who works in the clinical trial space, or who has an interest in medicine development. And is definitely for you if you’ve embraced the mindset shift towards putting patients first, but find you’re still facing barriers to achieving this ideal in the real world. We’ve collated all the current best thinking in the patient-first space, distilling it into a practical and actionable roadmap to guide your future progress.  Comment ‘patient first’ in the comments below 👇 and we’ll send you a private link to access the report as soon as it’s published. #PatientFirst #PatientEngagement #PatientInvolvement

Welcome Chrissie, our new Senior Account Manager! ⭐ #Team #HealthcareCommunications #WherePeopleMatter

Embracing sustainability every day in clinical trials 🌍 Within Pharma and healthcare, just like every industry, sustainability should never be treated as just a buzzword; it’s a daily commitment that is transforming the future of clinical trials. From managing energy consumption to reducing the need for travel and minimising waste, every decision counts towards lowering a trial’s carbon footprint. Below are five impactful steps to ensure your studies are eco-friendly and efficient.💡 Interested in making your clinical trials more sustainable? Speak to us today and discover how we can help you achieve your sustainability goals. #Sustainability #ClinicalTrials #AI #DigitalHealth

Recently Jon Hume, our Commercial Director here at Cuttsy+Cuttsy was invited to attend the European Haematology Association (EHA) Conference in Madrid as part of his training with Myeloma Patients Europe (MPE) Advocacy Development Programme. The event provided plenty of valuable learning opportunities. Here are the top 3️⃣ points Jon picked out from the conference, relevant to anyone working on patient materials and clinical trials support space ➡ 🔷 In the haematology space, trials often continue to add more drugs into the regimen to see improved results for patients. This brings with it a greater burden for patients with more information to process, more drugs to take and potentially more symptoms to manage. Therefore, studies involving this many treatments require highly tailored patient communications and everyone involved need the opportunity to talk with patients about their concerns. 🔷 Bispecifics are a type of promising new treatment that generate a dual attack on cancer cells. Side effects from this treatment can be managed by supportive care, but the more we can help to engage and educate patients on potential side effects, the more likely they are to seek help when they occur. 🔷 Gene therapy, specifically CAR T-cell therapy is a complex and specialist treatment providing incredible results for some patients. However, due to its complexity, trials involving CAR T are complex and often take a long time to recruit the right patients. Therefore, its important that support materials are highly adept in explaining concepts to patients, especially during the period at the beginning of the trial when they are waiting to receive their edited T-cells. Alongside the need for greater patient involvement, there are plenty of opportunities for us to support everyone delivering clinical trials by helping them to add value and improving patients’ lives. #EHA2024 #PatientCare #ClinicalTrials